News and Updates

Normally, the kidneys filter waste and extra water out of your blood to make urine. When your kidneys are damaged, they can’t filter blood like they should.

This educational content is made possible with support from Abbott, the makers of the FreeStyle Libre 2. Editorial control rests solely with Breakthrough T1D. Hannah M. was diagnosed with type 1 diabetes (T1D) at 3 years old in 2000 and remembers how afraid she was of having to prick her finger. She had the tale-tell […]

The 13th nPOD Annual Meeting was held February 22-24, 2021, and featured some of the most world-renowned diabetes investigators.

Breakthrough T1D has partnered with the Lupus Research Alliance and the National Multiple Sclerosis Society to advance the understanding of autoimmunity.

The Breakthrough T1D New England Center of Excellence will focus on protecting the stem cell-derived beta cells from rejection by the immune system after transplantation.

Type 1 diabetes is one of the only major autoimmune diseases that doesn't have a disease-modifying therapy. A Breakthrough T1D clinical trial is aiming to change that.

Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).

Douglas Melton, Ph.D., can now produce unlimited quantities of beta cells. He now wants to evade the immune attack. See our video to find out more.

The FDA regulatory review is now under way for teplizumab, to prevent or delay T1D in at-risk individuals. The target action date is July 2, 2021.

It’s been a tough year, to say the least. But there’s news that we can be proud of in type 1 diabetes research and advocacy. Really proud of.